Related references
Note: Only part of the references are listed.Nimotuzumab plus platinum-based chemotherapyversusplatinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Yunshu Zhu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial
C. Zhao et al.
ANNALS OF ONCOLOGY (2019)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
Qi Yang et al.
EUROPEAN JOURNAL OF CANCER (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Anti-epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Hao Peng et al.
CANCER SCIENCE (2018)
Nimotuzumab: beyond the EGFR signaling cascade inhibition
Zaima Mazorra et al.
SEMINARS IN ONCOLOGY (2018)
The Efficacy and Safety of Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Nasopharyngeal Carcinoma: Literature-based Meta-analyses
Liang Peng et al.
JOURNAL OF CANCER (2018)
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
Su-Mei Cao et al.
EUROPEAN JOURNAL OF CANCER (2017)
Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma
Rui You et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis
Wei-Xiong Xia et al.
ORAL ONCOLOGY (2017)
Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance
Lisa Y. Pang et al.
ONCOTARGET (2017)
Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up
Rui You et al.
THERANOSTICS (2017)
Molecular chess? Hallmarks of anti-cancer drug resistance!
Ian A. Cree et al.
BMC CANCER (2017)
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun et al.
LANCET ONCOLOGY (2016)
Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study
T. Xu et al.
ORAL ONCOLOGY (2015)
LONG-TERM OUTCOMES OF EARLY-STAGE NASOPHARYNGEAL CARCINOMA PATIENTS TREATED WITH INTENSITY-MODULATED RADIOTHERAPY ALONE
Sheng-Fa Su et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The ERBB network: at last, cancer therapy meets systems biology
Yosef Yarden et al.
NATURE REVIEWS CANCER (2012)
TREATMENT OUTCOMES AFTER RADIOTHERAPY ALONE FOR PATIENTS WITH EARLY-STAGE NASOPHARYNGEAL CARCINOMA
Wei-Wei Xiao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
RE-EVALUATION OF 6TH EDITION OF AJCC STAGING SYSTEM FOR NASOPHARYNGEAL CARCINOMA AND PROPOSED IMPROVEMENT BASED ON MAGNETIC RESONANCE IMAGING
Yan-Ping Mao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
Nancy Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Treatment Outcomes for Radiotherapy Alone are Comparable With Neoadjuvant Chemotherapy Followed by Radiotherapy in Early-Stage Nasopharyngeal Carcinoma
Chang Hoon Song et al.
LARYNGOSCOPE (2008)
The role of the EGFR signaling in tumor microenvironment
Antonella De Luca et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution
Jun-Lin Yi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy
DTT Chua et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma - A prospective study
BBT Ma et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2003)
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma
SL Wolden et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
